Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
| Revenue (Most Recent Fiscal Year) | $1.16B |
| Net Income (Most Recent Fiscal Year) | $168.10M |
| PE Ratio (Current Year Earnings Estimate) | 29.04 |
| PE Ratio (Trailing 12 Months) | 28.26 |
| PEG Ratio (Long Term Growth Estimate) | 2.41 |
| Price to Sales Ratio (Trailing 12 Months) | 6.27 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.79 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 20.89 |
| Pre-Tax Margin (Trailing 12 Months) | 13.48% |
| Net Margin (Trailing 12 Months) | 10.89% |
| Return on Equity (Trailing 12 Months) | 13.17% |
| Return on Assets (Trailing 12 Months) | 10.17% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.71 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.58 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.16 |
| Inventory Turnover (Trailing 12 Months) | 2.22 |
| Book Value per Share (Most Recent Fiscal Quarter) | $12.87 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.50 |
| Earnings per Share (Most Recent Fiscal Year) | $1.57 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.82 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 156.77M |
| Free Float | 150.65M |
| Market Capitalization | $7.58B |
| Average Volume (Last 20 Days) | 2.30M |
| Beta (Past 60 Months) | 1.46 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 98.95% |
| Annual Dividend (Based on Last Quarter) | $0.32 |
| Dividend Yield (Based on Last Quarter) | 0.66% |